The number of daily new cases of COVID-19 has surged over the past week in the United States, as the government eliminates all remaining restrictions on the spread of the disease even as the dangerous Delta variant becomes prevalent.
In the United States, where the Delta variant has been detected in all 50 states, daily cases have turned upwards, having risen 14.8 percent compared to the previous week.
In Europe, COVID-19 cases have surged 29 percent higher than the previous week.
There will be a new wave in the WHO European region unless we remain disciplined, warned WHO Regional Director for Europe Hans Kluge.
The Delta variant of the coronavirus (B.1.617.2), which ravaged India in May, has now rapidly swept across more than 85 countries, frustrating many countries that had planned to lift restrictions and reopen their economies before the summer tourist season. Only in South America has the Gamma variant, also known as P.1, remained dominant and is ravaging the continent.
Presently, according to Worldometer, there have been over 183 million cases of COVID-19 worldwide. The death count is fast approaching 4 million. However, this is known to be a gross underestimation, with modeling studies suggesting the death toll could be a magnitude of three times higher.
Despite the weeks of declines beginning in the early part of April, the global incidence of cases is again rising. Yesterday, the seven-day average stood at 378,000 COVID-19 cases. The seven-day moving average for deaths continues to remain high at over 8,000 per day. Though deaths continue to decline, they lag the trends in COVID cases and are expected to follow in step in the next week or two.
In the United States, increases have been most prominent in Southern and Western states, where vaccination rates are below the national averages, according to the Center for Infectious Disease Research and Policy.
Dr. Anthony Fauci said this week: Im very concerned about the stark disparity between places with low and high vaccination rates. When you have such a low level of vaccination superimposed upon a variant that has a high degree of efficiency of spread, what you are going to see among under-vaccinated regionsbe those states, cities or countiesyoure going to see these individual types of blips. Its almost like its going to be two Americas.
The highest case rates were in Nevada and Arkansas, with a 55 percent increase over the past seven days. Missouri and Wyoming saw almost a 20 percent rise over a week. In all, the United States reported more than 14,000 new cases and 249 deaths yesterday. There have been more than 34.5 million COVID-19 cases and over 620,000 deaths during the pandemic.
Indeed, the Independence Day weekend will add fuel to the fire. The holiday is expected to be the busiest travel period since the pandemic. Approximately 48 million people are planning to travel, primarily by car. AAA (American Automobile Association) forecasted that 3.5 million people would be flying, bringing airlines back to 90 percent of pre-pandemic traffic.
Eric Topol, professor of molecular medicine at the Scripps Research Institute, said of the Delta variant: It is the most hyper-transmissible, contagious version of the virus weve seen to date, for sureits a superspreader strain if there ever was one. Also, recent studies indicate that the Delta variant may produce more severe disease. A recent study published in The Lancet on June 14, noted that hospitalization rates of patients with the Delta strain were about 85 percent higher than those that were infected with the Alpha variant.
Despite the Centers for Disease Control and Preventions (CDC) recommendation that vaccinated individuals need not wear masks, health officials in Los Angeles strongly encouraged everyone, regardless of their vaccine status, to wear them indoors due to the threat posed by the highly transmissible strain of the coronavirus. During their last press briefing on COVID-19, the World Health Organization also recommended that all people wear masks indoors, including fully vaccinated people.
The United States vaccination campaign has stalled, remaining precariously at around 1 million vaccinations per day. Only 46.7 percent of the population has been fully vaccinated, with 54.4 percent having received at least a single dose. The current projections place August 2 as the estimated date when at least 70 percent of all adults in the US will have received at least one dose of the COVID vaccines, far behind the White Houses estimations.
The situation in Russia is growing direr by the day as deaths have surpassed the winter highs. Yesterday, 672 had succumbed to the infection, with 124 deaths in Moscow and 110 in St. Petersburg. Still, thousands of supporters were permitted to view the games as the quarter-final matches between Spain and Switzerland were given the go-ahead as planned. Meanwhile, Moscows Mayor Sergei Sobyanin confirmed that nearly 2,000 people are being hospitalized daily.
Sixty-five percent of the population have received at least one dose of the COVID vaccines in the UK. Still, there has been a 67 percent increase in cases of COVID-19 from a week before. The Delta variant now accounts for 97 percent of all COVID cases. Yesterday, they reported close to 28,000 new infections in contrast to just 3,165 on June 1. The epidemiological curves are rising exponentially.
Hans Kluge, Europes regional director for the WHO, has blamed these reversals in trends in relaxing restrictions and increased travel as the tourist season gets underway. Additionally, the Euro 2020 soccer tournament has drawn huge crowds of spectators from numerous countries mixing in crowded surroundings. Restaurants, pubs and bars are filled with patrons. Public transportation is brimming with fans and spectators. Reuters reported that this week almost 2,000 people from Scotland traveled to London for their game against England while infected with COVID-19.
I am not here to pour cold water on any EURO 2020 fan of anyones holidays, Kluge said. But before we watch our players, and before we all pack and go for some well-deserved rest near home or far away, it is my imperative to give [some]messages. If you decide to travel and gather, assess the risks and do it safely, keeping all life-saving reflexes of masks and self-protection, especially indoors and in crowds. He warned that Europe would be Delta dominant by August. He also noted that vaccination rates remain too slow.
Germanys Interior Minister Horst Seehofer had more choice words for the Union of European Football Associations (UEFA), calling them absolutely irresponsible for allowing 40,000 fans to watch the match between Germany and England at Wembley Stadium on Tuesday. I have the suspicion that this is about commerce again, he said. And commerce must not outshine the protection of the population against infection.
Dr. Eric Feigl-Ding, who has been prominent in educating the public on the pandemic and the science behind the SARS-CoV-2 virus, tweeted: Anyone who doubts the delta variant wave is coming only needs to look at Israel and the UKtwo of the most heavily vaccinated countries in the world.
Support the socialist program to stop the pandemic!
See the article here:
World Health Organization warns of new pandemic wave as cases surge in Europe and US - WSWS
- Exercise promotes a molecular profile in muscle: Research - January 21st, 2023
- Molecular Diagnostics Laboratory < Laboratory Medicine - January 4th, 2023
- Molecular cloning - Wikipedia - December 18th, 2022
- Trends in Molecular Medicine | Journal - ScienceDirect - December 10th, 2022
- Researchers from Insilico Medicine, University of Copenhagen, and University of Chicago unravel molecular secrets hidden in premature aging diseases... - December 2nd, 2022
- Nuclear Medicine and Molecular Imaging Week: October 2-8, 2022 - October 29th, 2022
- Biochemistry & Molecular Biology | Medicine - October 29th, 2022
- Cellular and Molecular Medicine | Faculty of Medicine - October 21st, 2022
- Molecular Diagnostics > Fact Sheets > Yale Medicine - October 21st, 2022
- Expert Reviews in Molecular Medicine | Cambridge Core - October 13th, 2022
- UT Southwestern ranked top health care institution globally for published research by Nature Index - UT Southwestern - October 13th, 2022
- Common Antibiotics Are Losing Their Potency. Researchers Pinpoint Mechanism to Restore It. - NYU Langone Health - October 13th, 2022
- expert reaction to study looking at integrating human stem cell-derived brain-like tissue in the brains of newborn rats - Science Media Centre - October 13th, 2022
- HTG Provides Update on Third Quarter Progress Toward Its Transcriptome-Informed Approach to Drug Discovery - Yahoo Finance - October 13th, 2022
- UVA Discovers Key Driver of High Blood Pressure - UVA Health Newsroom - October 13th, 2022
- Postdoctoral Fellow in Lung Cancer Genomics job with NORWEGIAN UNIVERSITY OF SCIENCE & TECHNOLOGY - NTNU | 311727 - Times Higher Education - October 13th, 2022
- Common cold may increase the risk of long Covid - Earth.com - October 13th, 2022
- Caris' Precision Oncology Alliance Welcomes The Cancer Institute at The University of Tennessee Medical Center - PR Newswire - October 13th, 2022
- Merus Announces Publication of Abstract on MCLA-129 at the 34th EORTC/NCI/AACR (ENA) Symposium on Molecular Targets and Cancer Therapeutics - Yahoo... - October 13th, 2022
- Molecular Test Could Improve Early Detection of Pancreatic Cancer - Technology Networks - October 13th, 2022
- UTSW researchers identify key player in cellular response to stress - EurekAlert - October 4th, 2022
- New Antibody Demonstrates Therapeutic Benefits Against Alzheimers - SciTechDaily - October 4th, 2022
- Mount Sinai study uncovers mechanisms of reactive oxygen species in stem cell function and inflammation prevention - EurekAlert - October 4th, 2022
- NovoPath Pushes the Limits of Laboratory Information Systems with Integrated Workflows for Genetic and Molecular Testing - PR Newswire - October 4th, 2022
- Postdoctoral Fellow in Bioinformatics job with NORWEGIAN UNIVERSITY OF SCIENCE & TECHNOLOGY - NTNU | 311073 - Times Higher Education - October 4th, 2022
- Breast Cancer Awareness | Nick Jacobs | An unlikely partnership: The United States Army Space and Missile Defense Command and the Joyce Murtha Breast... - October 4th, 2022
- Tackling resistance to HIF2 drugs with an RNA-based therapy - UT Southwestern - October 4th, 2022
- OncoNano Medicine Announces Positive Phase 2 Data for Pegsitacianine as an adjunct to Cytoreductive Surgery of Peritoneal Carcinomatosis - Business... - October 4th, 2022
- SIMATS organizes Induction Ceremony - Afternoonnews - Afternoon News - October 4th, 2022
- ExPath Grad Student Madeline Mayday Awarded Grant from the NIDDK Cooperative Centers of Excellence in Hematology - Yale School of Medicine - September 25th, 2022
- Blood Cancer Discovery Publication Further Validates Exscientia's AI Precision Medicine Platform for Improving Patient Outcomes - Business Wire - September 25th, 2022
- New Startups Built From UC Davis Innovations Drive Solutions in Food, Health and Agriculture - University of California, Davis - September 25th, 2022
- Scientists Discover New Cancer Treatment - The Morning News - September 25th, 2022
- Rewriting the Textbook for Precision Medicine - Technology Networks - September 25th, 2022
- Biden says 'The pandemic is over,' but health experts disagree - Chief Healthcare Executive - September 25th, 2022
- Discovery Illuminates How Parkinson's Disease Spreads in The Brain - Weill Cornell Medicine Newsroom - September 25th, 2022
- AI Used to Determine Cause of Alzheimer's and Related Disorders - Inside Precision Medicine - September 25th, 2022
- Looking Ahead in the Treatment of Breast Cancer - Targeted Oncology - September 25th, 2022
- Researchers identify potential biomarker to distinguish two aggressive types of brain tumors in children - EurekAlert - September 25th, 2022
- New study reveals breakthrough infections increase immunity to COVID-19 - OHSU News - September 25th, 2022
- Coronavirus Today: Who's dying of COVID-19 now? - Los Angeles Times - September 25th, 2022
- Hoag Named Radiopharmaceutical Therapy Center of Excellence, Publishes Results of Breast and Prostate Cancer Trials - PR Newswire - September 8th, 2022
- Orbital Therapeutics Launches to Advance New Frontiers of Science with the Next Generation of Innovative RNA Medicines - Yahoo Finance - September 8th, 2022
- Scientists urged the Biden administration to launch an Operation Warp Speed to develop inhaled COVID vaccines. China beat the U.S. to the punch -... - September 8th, 2022
- Foundation Medicine to Share 14 Abstracts at the 2022 European Society for Medical Oncology (ESMO) Congress Demonstrating the Power of Genomic... - September 8th, 2022
- Monte Rosa Therapeutics Announces FDA Clearance of Investigational New Drug Application for MRT-2359, a GSPT1-directed Molecular Glue Degrader Phase... - September 8th, 2022
- Biden administration says the once-a-year shot phase of the COVID-19 pandemic has arrived - The Boston Globe - September 8th, 2022
- ICCBS welcomes students of MPhil and PhD Programs 2022 - The Academia Mag - September 8th, 2022
- Exciting PhD positions at the European Molecular Biology Laboratory (EMBL) job with EUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL) | 308114 - Times... - September 8th, 2022
- Congratulations to our NRF award winners | UCT News - University of Cape Town News - September 8th, 2022
- Patients with some forms of aggressive esophageal cancers may benefit from treatment targeting how cells self-regulate - EurekAlert - September 8th, 2022
- Molecular Medicine (M.Sc.) - Georg-August-Universitt Gttingen - August 30th, 2022
- Gradalis Announces Publication in Nature Communications Medicine Identifying Survival Predicting Biomarker in Patients with Ovarian Cancer Treated... - August 30th, 2022
- Feinstein Institutes Get $3M From Lupus Research Alliance to Study Remission and Future Therapies - Business Wire - August 30th, 2022
- Unlocking the Power of Precision Medicine the Rheumatology Example - Technology Networks - August 30th, 2022
- When to trust your covid test results and when to question them | Mint - Mint - August 30th, 2022
- Molecular Diagnostics Market Report 2022-2030: Increasing Adoption of Point-Of-Care (Poc) Testing and the Development of Novel Assays Presents... - August 30th, 2022
- Advancing Precision Oncology, Ochsner Health First to Fully Integrate with Tempus and Epic's Genomics Module - Newswise - August 30th, 2022
- Tiny, Touch-Based Sensor Could Help Patients Stay on Top of Their Medications - SciTechDaily - August 30th, 2022
- Stellar Scholars Join CLAS Faculty - UConn Today - University of Connecticut - August 30th, 2022
- COVID-19 gave new urgency to the science of restoring smell - Science News Magazine - August 30th, 2022
- Dr. Sun lab wins R01 from National Institutes of Health to study liver proteins - Wayne State University - August 22nd, 2022
- Pasithea Therapeutics to Present Results of Tolerizing Vaccine Program at Prestigious International Immunotherapy Conference - GlobeNewswire - August 22nd, 2022
- New Study Identifies How A Group Of Genes Are Linked To Behavioral Conditions - Forbes - August 22nd, 2022
- New gene variant that protects against coronary heart disease uncovered - EurekAlert - August 22nd, 2022
- How a Japanese Herbal Medicine Protects the Gut Against Inflammatory Bowel Disease - Neuroscience News - August 22nd, 2022
- Insilico Medicine presents on AI for drug discovery at 9th Annual Aging Research and Drug Discovery Conference - EurekAlert - August 22nd, 2022
- Why polio is back on the radar of Canadian health officials - Brighter World - August 22nd, 2022
- Angela DeMichele, MD, MSCE, Assesses the Value of I-SPY2 for Neoadjuvant Treatment of Early Breast Cancer - Cancer Network - August 22nd, 2022
- Exciting PhD positions at the European Molecular Biology Laboratory (EMBL) job with EUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL) | 304753 - Times... - August 22nd, 2022
- Sensor could help patients stay on top of their meds - EurekAlert - August 22nd, 2022
- Trivitron Healthcare launches CoE in metabolomics, genomics, newborn screening and molecular diagnostics - Express Healthcare - August 22nd, 2022
- Research Trends of Moxibustion Therapy for Pain Treatment Over the Pas | JPR - Dove Medical Press - August 22nd, 2022
- Edited Transcript of EXAI.OQ earnings conference call or presentation 18-Aug-22 12:30pm GMT - Yahoo Finance - August 22nd, 2022
- Roche launches COVID-19 test that detects and differentiates the emerging variant of interest BA.2.75 - PR Newswire - August 22nd, 2022
- Will Omicron BA.5 Be the Last of the COVID Variants? - The Epoch Times - August 22nd, 2022
- Many Paths to Failure | Harvard Medical School - Harvard Medical School - August 5th, 2022
- Mitochondrial DNA Mutations Linked to Heart Disease Risk - University of California San Diego - August 5th, 2022
- UC Davis Sets a New Record, Surpasses $1 Billion in Research Funding - University of California, Davis - August 5th, 2022
- A first update on mapping the human genetic architecture of COVID-19 - Nature.com - August 5th, 2022